Detalhe da pesquisa
1.
Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma.
BMC Cancer
; 23(1): 404, 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142983
2.
Plasma anti-myosin autoantibodies in the diagnosis of necrotizing enterocolitis.
Eur J Pediatr
; 182(11): 5203-5210, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715022
3.
Prognostic values and immune suppression of the S100A family in pancreatic cancer.
J Cell Mol Med
; 25(6): 3006-3018, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580614
4.
Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer.
J Cell Mol Med
; 24(22): 13481-13493, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33073486
5.
A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer.
Cancer Cell Int
; 20: 493, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33061845
6.
LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal adenocarcinoma by targeting SMAD4.
Biol Direct
; 19(1): 24, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504385
7.
Current status and progress in laparoscopic surgery for gallbladder carcinoma.
World J Gastroenterol
; 29(16): 2369-2379, 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37179580
8.
A hierarchical prognostic model for Co-diabetes pancreatic adenocarcinoma.
Heliyon
; 9(11): e21642, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027595
9.
An injectable thermosensitive hydrogel loaded with a theranostic nanoprobe for synergistic chemo-photothermal therapy for multidrug-resistant hepatocellular carcinoma.
J Mater Chem B
; 10(15): 2828-2843, 2022 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316319
10.
ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway.
J Exp Clin Cancer Res
; 41(1): 130, 2022 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392973
11.
Identification of MBOAT2 as an Unfavorable Biomarker Correlated with KRAS Activation and Reduced CD8+ T-Cell Infiltration in Pancreatic Cancer.
J Oncol
; 2022: 4269733, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35571489
12.
Genome-Wide CRISPR/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma.
Int J Biol Sci
; 18(11): 4357-4371, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35864956
13.
Predictive factors for rapid progression in preterm neonates with necrotizing enterocolitis.
Front Pediatr
; 10: 970998, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36699309
14.
Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer.
Heliyon
; 8(11): e11321, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36406681
15.
Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8+ T Cell Infiltration.
Front Mol Biosci
; 8: 602227, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33816550
16.
A Novel Blood Index-Based Model to Predict Hepatitis B Virus-Associated Hepatocellular Carcinoma Recurrence After Curative Hepatectomy: Guidance on Adjuvant Transcatheter Arterial Chemoembolization Choice.
Front Oncol
; 11: 755235, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35004275
17.
Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy.
Clin Med Insights Oncol
; 15: 11795549211024149, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211308
18.
CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer.
J Cancer
; 12(19): 5797-5806, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34475993
19.
SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 8: 899-912, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34395329
20.
Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer.
Biomed Res Int
; 2021: 9949272, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34660806